In force Publication date 25 May 15
Pharmacogenomics of inhaled Beta2-agonists and athletic performance
Project Title: Pharmacogenomics of Inhaled Beta2-agonists and athletic performance
Researchers: M. Koehle, J. Rupert, D. McKenzie (University of British Columbia, Canada); B. Sporer (Canadian Sport Centers Pacific)
Year accepted: 2009
Summary: We hypothesize that a subgroup of athletes with certain genetic variations will benefit from 2-agonists while the rest will not. If some athletes are achieving enhanced performance from asthma medication, then the rules surrounding their use in sport will need to be reviewed.
Available in 1 language.